Home > Financial Ratios > DIVIS LABORATORIES

DIVIS LABORATORIES
Core EBITDA Growth

    Back to All Ratios
DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for DIVIS LABORATORIES
Please provide your vote to see the results

DIVIS LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 30.49-6.23-32.1036.7145.25

What is the latest Core EBITDA Growth ratio of DIVIS LABORATORIES ?

The latest Core EBITDA Growth ratio of DIVIS LABORATORIES is 30.49 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202530.49
Mar2024-6.23
Mar2023-32.10
Mar202236.71
Mar202145.25

How is Core EBITDA Growth of DIVIS LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 30.49
Positive
Mar2024 -6.23
Negative
Mar2023 -32.1
Negative
Mar2022 36.71
-18.87
Mar2021 45.25 -

Other Financial Ratios of DIVIS LABORATORIES


Compare Core EBITDA Growth ratio of peers of DIVIS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DIVIS LABORATORIES ₹184,075.1 Cr 2.4% 4.2% -1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹461,644.0 Cr 1.1% 7.2% 15.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹167,464.0 Cr 1.9% 8.3% 45.6% Stock Analytics
CIPLA ₹115,263.0 Cr -1.8% 3.2% -4.9% Stock Analytics
MANKIND PHARMA ₹103,631.0 Cr -0.9% 5.8% 3.5% Stock Analytics
DR REDDYS LABORATORIES ₹103,049.0 Cr -8.8% -3.2% -4.6% Stock Analytics


DIVIS LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
DIVIS LABORATORIES

2.4%

4.2%

-1%

SENSEX

-0.9%

4.9%

-6.8%


You may also like the below Video Courses